Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S304-S314

  Shulman, Lester M ^a,c   Mendelson, Ella ^a,c   Anis, Emilia ^d,e,h   Bassal, Ravit ^b   Gdalevich, Michael ^a,i   Hindiyeh, Musa ^a,c   Kaliner, Ehud ^e   Kopel, Eran ^d,e   Manor, Yossi ^a   Moran Gilad, Jacob ^e   Ram, Daniella ^a   Sofer, Danit ^a   Somekh, Eli ^c,f,j   Tasher, Diana ^j   Weil, Merav ^a   Gamzu, Ronni ^c,g   Grotto, Itamar ^e,i  

^a MINISTRY OF HEALTH   (Israel)

^b Israel Center for Disease Control   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Division of Epidemiology   (Israel)

^e Public Health Services   (Israel)

^f Head National Committee for Monitoring Poliovirus   (United States)

^g Strategic and Participatory Management Secretariat The Ministry of Health   (United States)

^h HEBREW UNIVERSITY OF JERUSALEM   (Israel)

ⁱ BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^j WOLFSON MEDICAL CENTER   (Israel)

more..

Author keywords

emergency health policy response; environmental surveillance; epidemiology; molecular analysis; silent poliovirus transmission; vaccine; wild poliovirus

Indexed keywords

BIVALENT ORAL POLIOMYELITIS VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG; SEWAGE;

DISEASE SURVEILLANCE; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; ENVIRONMENTAL SURVEILLANCE; FECES ANALYSIS; HEALTH CARE POLICY; HIGH THROUGHPUT SEQUENCING; HISTORY OF MEDICINE; HUMAN; INFECTION RISK; ISRAEL; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK ASSESSMENT; ROUTINE VACCINATION; SENSITIVITY ANALYSIS; SEQUENCE HOMOLOGY; SEROLOGY; SEWAGE TREATMENT PLANT; SPECIES INTRODUCTION; SUSTAINED SILENT VIRUS TRANSMISSION; TREND STUDY; VACCINATION; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS TRANSMISSION; WILD POLIO VIRUS TYPE 1; DIAGNOSTIC PROCEDURE; ENVIRONMENTAL MONITORING; EPIDEMIOLOGY; FECES; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; SEWAGE; TRANSMISSION; VIROLOGY; VIRUS SHEDDING;

CLINICAL LABORATORY TECHNIQUES; ENVIRONMENTAL MONITORING; FECES; HUMANS; ISRAEL; MOLECULAR DIAGNOSTIC TECHNIQUES; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; SEWAGE; VIRUS SHEDDING;

EID: 84910629678     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu294     Document Type: Review

References (27)

1. Shulman LM. Polio and its epidemiology. In: Meyers RA, ed. Encyclopedia of sustainability science and technology. New York, NY: Springer, 2012:8123-73.
2. Daniel TM, Robbins FC. A history of poliomyelitis. In: Daniel TM, Robbins FC, eds. Polio. Rochester, NY: University of Rochester Press, 1997:5-22.
3. Swartz TA. The epidemiology of polio in Israel an historical perspective. Tel Aviv: Dyonon Pub. Ltd., 2008.
4. Shulman L M, Manor Y, Sofer D, Mendelson E. Bioterrorism and surveillance for infectious diseases-lessons from poliovirus and enteric virus surveillance. J Bioterr Biodef 2012; S4:004.
5. Manor Y, Blomqvis t S, Sofer D, et al. Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol 2007; 73:5954-8.
6. Manor Y, Handsher R, Halmut T, et al. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J Clin Microbiol 1999; 37:1670-5.
7. WHO. Report of the 26th Meeting of the European Regional Certification Commission for Poliomyelitis Eradication, Copenhagen, Denmark, 18-20 June, 2012. Copenhage, Denmark: WHO, 20 12. http://www.euro.who.int/-data/assets/pdf-file/0005/184739/e96806.pdf. Accessed 6 June 2014.
8. Sutter RW, Kew OM, Cochi SL. Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Saunders/Elsevier, 2008:631-85.
9. Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Saunders/Elsevier, 2008:605-29.
10. WHO. Polio laboratory manual. 4th ed. WHO/IVB/04.10. Geneva, Switzerland. WHO, 2004. http://whqlibdoc.who.int/hq/2004/WHO-IVB-04.10.pdf. Accessed 6 June 2014.
11. Hovi T, Sh ulman LM, van der Avoort H, Deshpande J, Roivainen M, EM DEG. Role of environmental poliovirus surveillance in global polio eradication and beyond. Epidemiol Infect 2012; 140:1-13.
12. WHO. Guidelines for environmental surveillance of poliovirus circulation. WHO, Dept of Vaccines and Biologicals, 2003. http://whqlibdoc.who.int/hq/2003/who-v&b-03.03.pdf. Accessed 6 June 2014.
13. Ranta J, Hovi T, Ar jas E. Poliovirus surveillance by examining sewage water specimens: studies on detection probability using simulation models. Risk Anal 2001; 21:1087-96.
14. DowdleW, van der Avoort H, de Gourville E, et al. Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management. Risk Anal 2006; 26:1449-69.
15. Hovi T, Shulman LM, van der Avoort H, Deshpande J, Roivainen M, de Gourville EM. Role of environmental poliovirus surveilllance in global polio eradication and beyond: a review. Epidemiol Infect 2011; 140:1-13.
16. Vinje J , Gregoricus N, Martin J, et al. Isolation and characterization of circulating type 1 vaccine-derived poliovirus from sewage and stream waters in Hispaniola. J Infect Dis 2004; 189:1168-75.
17. S hulman LM, Handsher R, Yang CF, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol 2000; 38:945-52.
18. Deshpande JM, Shetty SJ, Sidd iqui ZA. Environmental surveillance system to track wild poliovirus transmission. Appl Environ Microbiol 2003; 69:2919-27.
19. Anis E, Kopel E, Singer SR, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill 2013; 18:pii=20586. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20586. Accessed 6 June 2014.
20. Manor Y, Shulman LM, Hindiyeh M, et al . Intensified environmental surveillance supporting the response to wild-type poliovirus type 1 silent circulation in Israel, 2013. Euro Surveill 2014; 19:pii=20708. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=207 08. Accessed 6 June 2014.
21. Hindiyeh MY,Moran-Gilad J,Manor Y,et al. Development and validation of a quantitative RT-PCR assay for investigation of wild type poliovirus 1 (SOAS) reintroduced into Israel. Eur o Surveill 2014 19: pii=20710. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20710. Accessed 6 June 2014.
22. Kilpatrick DR, Yang CF, Ching K, et al. Rapid group-, serotype-, and vaccin e strain-specific identification of poliovirus isolates by realtime reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol 2009; 47: 1939-41.
23. Kew OM, Mulders MN, Lipskaya GY, de Silva E, Pallansch MA. Molecular Epidemiology of Polioviruses. Semin Virol 1995; 6:401-5.
24. Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 2008; 82:4429-40.
25. Shulman LM, Gavrilin E, Jorba J, et al. Molecular epidemiology of silent introduction and su stained transmission of wild poliovirus type 1, Israel, 2013. Euro Surveill 2014;19:pii=20709. http://wwweurosurveillanceorg/ViewArticleaspx?ArticleId=20709. Accessed 6 June 2014.
26. Bassal R, Shohat T, Cohen D, et al. Survey to determine the level of vaccine coverage against poliovirus in the general population of Israel [in Hebrew]. Document 353. ICDC, 2013:1-8.
27. Kaliner E, Moran-Gilad J, Grotto I, et al. Silent reintroduction of wildtype poliovirus to Israel, 2013-risk communication challenges in an argumentative atmosphere. Euro Surveill 2014;19:pii=20703. http://wwweurosurveillanceorg/ViewArticleaspx?Arti cleId=20703. Accessed 6 June 2014.